| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0003261> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0005984> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0018724> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0022341> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C0587437> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C1704312> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34375755_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan.\', \'Department of Infectious Diseases, Chiba University Hospital, Japan.\', \'Department of Infectious Diseases, Chiba University Hospital, Japan; Chiba University Hospital COVID-19 Vaccine Center, Japan.\', \'Department of Public Health, Graduate School of Medicine, Japan.\', \'Department of Molecular Oncology, Graduate School of Medicine, Japan.\', \'Division of Laboratory Medicine, Chiba University Hospital, Japan.\', \'Clinical Research Centre, Chiba University Hospital, Japan.\', \'Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Japan.\', \'Department of Orthopaedic Surgery, Graduate School of Medicine, Japan.\', \'Department of General Thoracic Surgery, Graduate School of Medicine, Japan.\', \'Department of Frontier Surgery, Graduate School of Medicine, Japan.\', \'Department of Immunology, Graduate School of Medicine, Japan.\', \'Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: kyokote@faculty.chiba-u.jp.\', \'Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan; Chiba University Hospital COVID-19 Vaccine Center, Japan. Electronic address: nakajimh@faculty.chiba-u.jp.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Hanaoka_Hideki> <https://research.tib.eu/covid-19/entity/Igari_Hidetoshi> <https://research.tib.eu/covid-19/entity/Ikeda_Kei> <https://research.tib.eu/covid-19/entity/Kageyama_Takahiro> <https://research.tib.eu/covid-19/entity/Kaneda_Atsushi> <https://research.tib.eu/covid-19/entity/Matsubara_Hisahiro> <https://research.tib.eu/covid-19/entity/Matsushita_Kazuyuki> <https://research.tib.eu/covid-19/entity/Nakada_Taka-Aki> <https://research.tib.eu/covid-19/entity/Nakajima_Hiroshi> <https://research.tib.eu/covid-19/entity/Nakayama_Toshinori> <https://research.tib.eu/covid-19/entity/Ohtori_Seiji> <https://research.tib.eu/covid-19/entity/Onouchi_Yoshihiro> <https://research.tib.eu/covid-19/entity/Tanaka_Shigeru> <https://research.tib.eu/covid-19/entity/Taniguchi_Toshibumi> <https://research.tib.eu/covid-19/entity/Yokote_Koutaro> <https://research.tib.eu/covid-19/entity/Yoshino_Ichiro>
?:doi	<https://research.tib.eu/covid-19/entity/S1198-743X%2821%2900437-710.1016/j.cmi.2021.07.042>
?:doi	S1198-743X(21)00437-710.1016/j.cmi.2021.07.042
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34375755>
?:pmid	<https://research.tib.eu/covid-19/entity/34375755>
?:pmid	34375755
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan.\', \'Department of Infectious Diseases, Chiba University Hospital, Japan.\', \'Department of Infectious Diseases, Chiba University Hospital, Japan; Chiba University Hospital COVID-19 Vaccine Center, Japan.\', \'Department of Public Health, Graduate School of Medicine, Japan.\', \'Department of Molecular Oncology, Graduate School of Medicine, Japan.\', \'Division of Laboratory Medicine, Chiba University Hospital, Japan.\', \'Clinical Research Centre, Chiba University Hospital, Japan.\', \'Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Japan.\', \'Department of Orthopaedic Surgery, Graduate School of Medicine, Japan.\', \'Department of General Thoracic Surgery, Graduate School of Medicine, Japan.\', \'Department of Frontier Surgery, Graduate School of Medicine, Japan.\', \'Department of Immunology, Graduate School of Medicine, Japan.\', \'Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: kyokote@faculty.chiba-u.jp.\', \'Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan; Chiba University Hospital COVID-19 Vaccine Center, Japan. Electronic address: nakajimh@faculty.chiba-u.jp.\']

?:citedBy